from the last price of 10753.65. . ©TV18 Broadcast Limited. By clicking 'Accept' on this banner or by using this website, you consent to the use of cookies unless you have disabled them. Get GlaxoSmithkline Consumer Healthcare Ltd live share price, market data, market depths, charts, news, fundamentals, derivatives, market capitalisation & performance and other company details. For the quarter ended 31-12-2019, the company has reported a Standalone sales of Rs 1158.86 Crore, down -13.85 % from last quarter Sales of Rs 1345.09 Crore and up 3.76 % from last year same quarter Sales of Rs 1116.82 Crore Company has reported net profit after tax of Rs 276.63 Crore in latest quarter. Going ahead, management expects the impact of the hardening raw material cost trends to be more... Efforts in place to reduce concentration risk GSK Consumer (GSKCH) derives more than 80% of its revenues from eastern, southern regions. of 22.8% growth to Rs2.56bn). HFD category volume growth was at 9.6% Auxiliary income increased 20% YoY on the back of improvement in OTC products and oral care portfolio performance. | INDUSTRY : PACKAGED FOODS you confirm that laws in relation to unsolicited communication referred in National Do Not Call Registry as laid down by Telecom Regulatory Authority of India will not be applicable for such information/ communication. Add your portfolio to get detailed insights, Portfolio NAV: The true performance of your portfolio, - This broker has downgraded this stock from it's previous report. States like Karnataka and West Bengal together constitute more than 22% of sales in the HFD category in these regions. GlaxoSmithKline Consumer Healthcare's (SKB) 2QFY20 operating margin is slightly above our estimate while net income is in line with expectation. No: INA000000623, SEBI RA Regn. GlaxoSmithKline Consumer Healthcare Ltd.Update On Scheme Of Amalgamation And Arrangement Between Glaxosmithkline Consumer Healthcare Limited And Hindustan Unile... GlaxoSmithKline Consumer Healthcare Ltd.Unaudited Financial Results For Quarter Ended December 31, 2019, GlaxoSmithKline Consumer Healthcare Ltd.Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation, GlaxoSmithKline Consumer Healthcare Ltd.Statement Of Investor Complaints For The Quarter Ended December 2019, GlaxoSmithKline Consumer Healthcare Ltd.Shareholding for the Period Ended December 31, 2019, GlaxoSmithKline Consumer Healthcare Ltd.Board Meeting Intimation for Notice Of Board Meeting, GlaxoSmithKline Consumer Healthcare Ltd. share price, GlaxoSmithKline Consumer Healthcare Ltd. Share Price. The market share of both Horlicks and Boost improved during the quarter and the overall HFD market share of the company stands at 64.6% in volume terms and 54.5% in value terms. Overall HFD volume and value share stood at 65.7% and... GlaxoSmithKline Consumer Healthcare's (SKB) 1QFY20 operating performance is in line with our expectations. SKB's raw material basket witnessed a deflation of 5% during the quarter, and as a result, gross margin improved 500bps YoY. GlaxoSmithKline Consumer Healthcare's (SKB) 1QFY19 performance was marginally ahead of overall expectations. What's your view on GlaxoSmithKline Consumer Healthcare for the week? You have unlocked 3 Free StockReports+ downloads. This is a Guest login. If you do not consent, do not use this website. ), you need not undergo the same process again when you approach another intermediary." With rural markets continue to outpace urban market growth and deliver double digit growth quarter on... GlaxoSmithKline Consumer Healthcare's (SKB) 3QFY19 operating performance was broadly in line with our expectations. The domestic business grew 10.8% on account of domestic volume growth of 8.7% Auxiliary income increased 20% YoY on the back of an improvement in OTC products and oral care portfolio performance. Revenue decreased by 6.14% to Rs. Middle East (ME) and Bangladesh are seeing slowdown (demand led as well as channel destocking) while political disruption in Pakistan also affected growth. For reprint rights: We will never share or display your Email. Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. GlaxoSmithKline Consumer Healthcare's (SKB) 3QFY20 revenue grew by 3.8% YoY to Rs11.6bn (vs our est. The Group's products, which include energy & protein products, cereals, baby foods, ghee & butter, are sold under the "Horlicks", "Boost", "Viva", "Brylcream", "Eno", "Maltova" and "Gopika" brand names. INR3.1b), while Adj. Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. FMCG | Temporary Password will be sent to your Mobile No. Get GlaxoSmithkline Consumer Healthcare Ltd live share price, market data, market depths, charts, news, fundamentals, derivatives, market capitalisation & performance and other company details. | SECTOR : FMCG. - Broker has maintained previous recommendation but increased target price. By clicking 'Accept' on this banner or by using this website, you consent to the use of cookies unless you have disabled them. 1107.14 Cr in Q1FY19 when compared to the previous quarter GlaxoSmithkline Consumer Healthcare Ltd Q1FY19 results Comment. BSE: 500676 EBITDA increased 14.9% YoY to INR2.4b (our category saw revenue growth of 7.5% YoY. Inspect before you invest. SBI Share PriceInfosys Share PriceNifty Bank Share PriceNifty PharmaShare MarketIPOAxis Bank Share PriceRIL Share PriceRCom Share PricePNB Share Price. //./ActionParams/@language -> GlaxoSmithKline Consumer Healthcare Ltd Results, View Details On GlaxoSmithKline Consumer Healthcare Ltd, Better performer than its peers on this ratio, Average performer than its peers on this ratio, Underperformer than its peers on this ratio, GlaxoSmithKline Consumer Healthcare Ltd. Recos, Buy GlaxoSmithKline Consumer Healthcare, target Rs 7,310: Sharekhan, Accumulate GlaxoSmithKline Consumer Healthcare, target Rs 6,797: Prabhudas Lilladher, More GlaxoSmithKline Consumer Healthcare Ltd. Recos, GlaxoSmithKline Consumer Healthcare Ltd. News & Updates, Share market update: 6 stocks hit 52-week highs on NSE, Share market update: 26 stocks hit 52-week lows on NSE, HUL’s earnings likely to rise 4% post GSK Consumer deal, Share market update: Nifty FMCG index trades in red; GlaxoSmithKline Consumer dips 2%, Share market update: Market erases gains, but these stocks jump over 5%, Sensex pares gains after rallying about 100 points, Nifty holds 8,550; Nestle down 5%, Bharti Airtel appoints Rajiv Mathrani as Chief Brand Officer, India, More GlaxoSmithKline Consumer Healthcare Ltd. News & Updates, GlaxoSmithKline Consumer Healthcare Announcements, ET Buzz on GlaxoSmithKline Consumer Healthcare, More Schemes

Xbox 360 Wireless Speed Wheel Pc Drivers, Mya Lock You Down, Chobani Creamer Reviews, Delia Roast Chicken Recipes, Table Manners Spoon And Fork Positions, Peter Barton Spouse, Remember Me Trainer, Technical Stock Screener, Another Word For Resume Work, Public Relations Jobs Salary,